Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insufficient Physical Activity”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Large-scale testing (Phase 3)Study completedNCT01126541
What this trial is testing

SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 224
Early research (Phase 1)Study completedNCT00541229
What this trial is testing

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 103
Large-scale testing (Phase 3)Study completedNCT01091675
What this trial is testing

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Who this might be right for
Ankylosing Spondylitis
Spanish Foundation of Rheumatology 58
Large-scale testing (Phase 3)Study completedNCT02721966
What this trial is testing

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

Who this might be right for
Axial Psoratic Arthritis
Novartis Pharmaceuticals 503
Large-scale testing (Phase 3)Study completedNCT00683657
What this trial is testing

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 93
Large-scale testing (Phase 3)Study completedNCT02324569
What this trial is testing

A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 240
Large-scale testing (Phase 3)Active Not RecruitingNCT06672172
What this trial is testing

HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 284
Post-approval studies (Phase 4)Study completedNCT01717222
What this trial is testing

Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy

Who this might be right for
Pain, PostoperativeAnalgesic RequirementStress Response+2 more
Jawaharlal Institute of Postgraduate Medical Education & Research 50
Large-scale testing (Phase 3)Study completedNCT02946541
What this trial is testing

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Who this might be right for
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT01431807
What this trial is testing

Long-term Study of SYR-472

Who this might be right for
Diabetes Mellitus
Takeda 680
Large-scale testing (Phase 3)Study completedNCT01095653
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,179
Large-scale testing (Phase 3)Study completedNCT01703221
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 414
Not applicableLooking for participantsNCT06528639
What this trial is testing

A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases（C-MET Trial）

Who this might be right for
Metabolic Syndrome
Peking University Third Hospital 220
Testing effectiveness (Phase 2)Study completedNCT01405911
What this trial is testing

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

Who this might be right for
Glucose Intolerance
Merck Sharp & Dohme LLC 242
Large-scale testing (Phase 3)Active Not RecruitingNCT05782907
What this trial is testing

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
AbbVie 122
Large-scale testing (Phase 3)Study completedNCT02173457
What this trial is testing

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 740
Testing effectiveness (Phase 2)Study completedNCT01193218
What this trial is testing

Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547
Post-approval studies (Phase 4)Study completedNCT01399697
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 261
Large-scale testing (Phase 3)Active Not RecruitingNCT05814627
What this trial is testing

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 487
Large-scale testing (Phase 3)Ended earlyNCT03760965
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 276
Load More Results